{"abstract": "Patients taking the drug anacetrapib had a 39.8 percent reduction in bad cholesterol and a 138.1 percent increase in good cholesterol.", "web_url": "https://www.nytimes.com/2010/11/18/health/research/18merck.html", "snippet": "Patients taking the drug anacetrapib had a 39.8 percent reduction in bad cholesterol and a 138.1 percent increase in good cholesterol.", "lead_paragraph": "Merck has a potential blockbuster in anacetrapib, an experimental cholesterol drug that increases HDL, or \u201cgood\u201d cholesterol even as it lowers LDL, the \u201cbad\u201d cholesterol.", "print_section": "B", "print_page": "4", "source": "The New York Times", "multimedia": [], "headline": {"main": "Merck Drug for Cutting Cholesterol Is Promising", "kicker": null, "content_kicker": null, "print_headline": "Merck Drug For Cutting Cholesterol Is Promising", "name": null, "seo": null, "sub": null}, "keywords": [{"name": "organizations", "value": "Merck & Company Inc", "rank": 1, "major": "N"}, {"name": "subject", "value": "Cholesterol", "rank": 2, "major": "N"}, {"name": "subject", "value": "Drugs (Pharmaceuticals)", "rank": 3, "major": "N"}, {"name": "subject", "value": "Research", "rank": 4, "major": "N"}, {"name": "subject", "value": "Medicine and Health", "rank": 5, "major": "N"}], "pub_date": "2010-11-17T22:52:06+0000", "document_type": "article", "news_desk": "Business", "section_name": "Health", "subsection_name": "Research", "byline": {"original": "By Natasha Singer", "person": [{"firstname": "Natasha", "middlename": null, "lastname": "Singer", "qualifier": null, "title": null, "role": "reported", "organization": "", "rank": 1}], "organization": null}, "type_of_material": "News", "_id": "nyt://article/971caecd-4a2a-5ddf-aed2-e6535f8b467a", "word_count": 682, "uri": "nyt://article/971caecd-4a2a-5ddf-aed2-e6535f8b467a"}